| Name | Propranolol D7 |
|---|
| Description | Propranolol D7 hydrochloride is a deuterium labeled Propranolol hydrochloride. Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used to control hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 12 nM (βAR)[1] |
| References |
[3]. Al-Majed AA, et al. Propranolol. Profiles Drug Subst Excip Relat Methodol. 2017;42:287-338. |
| Molecular Formula | C16H15D7ClNO2 |
|---|---|
| Molecular Weight | 266.38700 |
| Exact Mass | 266.20100 |
| PSA | 41.49000 |
| LogP | 2.96840 |